<DOC>
	<DOCNO>NCT01988701</DOCNO>
	<brief_summary>This research trial study lymphocyte profile activation status patient graft-versus-host disease . Studying sample blood laboratory patient cancer may help doctor identify learn biomarkers relate graft-versus-host disease .</brief_summary>
	<brief_title>Lymphocyte Profiles Activation Status Patients With Graft-Versus-Host Disease</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To explore assess change subset activation status B- , T , - , natural killer ( NK ) lymphocytes peripheral blood follow allogeneic stem cell transplant may associate clinical event ultimate future goal conduct large successor study identify potential therapeutic target base finding . SECONDARY OBJECTIVES : I . To assess feasibility obtain compare patient chronic graft-versus-host disease ( cGVHD ) time-matched stem cell transplant ( SCT ) patient without cGVHD identify logistical challenge obtain processing sample subgroups interest analysis . II . To assess explore difference lymphocyte subset ( B- , T- , NK ) vs. without cGVHD . III . To assess explore difference cytokine patient cGVHD vs. without . IV . To describe lymphocyte subset activation explore may relate specific clinical manifestation cGVHD . OUTLINE : Blood sample analyze activation status B lymphocytes , T lymphocytes , NK lymphocytes via flow cytometry , enzyme-linked immunosorbent assay ( ELISA ) , enzyme-linked immunosorbent spot ( ELISPOT ) , immunoblot , microarray assay .</detailed_description>
	<mesh_term>Graft v Host Disease</mesh_term>
	<criteria>Allogeneic SCT group : Patients receive stem cell transplantation The Ohio State University eligible beyond day +75 follow allogeneic SCT regardless previous diagnosis acute chronic graftversushost disease ( GVHD ) Autologous SCT group : Patients receive autologous stem cell transplant The Ohio State University achieve platelet neutrophil engraftment</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>GVHD</keyword>
	<keyword>chronic Graft versus Host Disease</keyword>
</DOC>